UCSDI5 Sandbox - Local Development build (v0.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Official URL: http://hl7.org/fhir/us/uscdi5-sandbox/ImplementationGuide/hl7.fhir.us.uscdi5-sandbox | Version: 0.0.0 | |||
IG Standards status: Trial-use | Maturity Level: 0 | Computable Name: UCSDI5Sandbox | ||
Copyright/Legal: Used by permission of HL7 International, all rights reserved Creative Commons License |
testbed for ideas….
Overview: The LOINC Universal Lab Order Codes Value Set, also known as the "Common Lab Orders", is a collection of the most frequent lab orders. It was created for order entry system developers so that they could deliver them in HL7 messages to laboratories. On receipt, laboratories could understand and translate these universal codes into their internal processes for fulfillment.
This value set was developed iteratively through both empirical and consensus-driven approaches. The original version was developed by the NLM, Regenstrief Institute, and several organizations and contained an empirical list of the most commonly ordered tests. We often called that list the "Top 300", because it contained about 300 codes that accounted for the majority of the volume of five nationally-representative data sources.
In 2014, S&I Framework Initiative called "aLOINC Order Code" launched with the goal of enhancing and expanding the original list to more comprehensively cover tests commonly ordered in ambulatory care settings and for tests ordered in public health settings. The initative used a combination of empiric and consensus based approaches to identify additional LOINC codes to be added to the original list.
Columns:
Sort order: This file is sorted alphabetically by LOINC Long Common Name.
*Note: This file does not include any deprecated terms.
Row | LOINC | Long Common Name |
---|---|---|
1 | 53835-5 | 1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma |
2 | 31019-3 | 10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma |
3 | 6765-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma |
4 | 1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
5 | 32854-2 | 17-Hydroxyprogesterone [Presence] in DBS |
6 | 49054-0 | 25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
7 | 1989-3 | 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
8 | 62292-8 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
9 | 44907-4 | 5-Hydroxyindoleacetate panel - 24 hour Urine |
10 | 1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
11 | 19593-3 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
12 | 10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
13 | 51776-3 | 7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method |
14 | 882-1 | ABO and Rh group [Type] in Blood |
15 | 46268-9 | ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction |
16 | 19057-9 | ABO and Rh group [Type] in Blood from Newborn |
17 | 34530-6 | ABO and Rh group panel - Blood |
18 | 883-9 | ABO group [Type] in Blood |
19 | 3298-7 | Acetaminophen [Mass/volume] in Serum or Plasma |
20 | 35595-8 | Acetaminophen [Mass/volume] in Serum or Plasma by Screen method |
21 | 3297-9 | Acetaminophen [Presence] in Serum or Plasma |
22 | 3299-5 | Acetaminophen [Presence] in Urine |
23 | 5568-1 | Acetone [Mass/volume] in Serum or Plasma |
24 | 20469-3 | Acetone [Presence] in Serum or Plasma by Screen method |
25 | 5569-9 | Acetone [Presence] in Urine |
26 | 20427-1 | Acetylcholine receptor Ab [Moles/volume] in Serum |
27 | 11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum |
28 | 11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum |
29 | 30192-9 | Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum |
30 | 6066-5 | Acremonium sp IgE Ab [Units/volume] in Serum |
31 | 34661-9 | Actin IgG Ab [Units/volume] in Serum or Plasma |
32 | 3184-9 | Activated clotting time (ACT) of Blood by Coagulation assay |
33 | 48344-6 | Activated clotting time.kaolin induced of Platelet poor plasma |
34 | 13589-7 | Activated protein C resistance [Presence] in Blood by NAA with probe detection |
35 | 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
36 | 24363-4 | Acute hepatitis 2000 panel - Serum |
37 | 45270-6 | Acute leukemia panel - Specimen by Flow cytometry (FC) |
38 | 1721-0 | Adenosine triphosphate [Mass/volume] in Blood |
39 | 5834-7 | Adenovirus Ag [Presence] in Specimen by Immunofluorescence |
40 | 55160-6 | Adenovirus IgG and IgM panel - Serum |
41 | 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
42 | 1747-5 | Albumin [Mass/volume] in Body fluid |
43 | 1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid |
44 | 1751-7 | Albumin [Mass/volume] in Serum or Plasma |
45 | 1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
46 | 1763-2 | Aldosterone [Mass/volume] in Serum or Plasma |
47 | 55151-5 | Aldosterone and renin activity panel - Plasma |
48 | 6768-6 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma |
49 | 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
50 | 17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
51 | 6019-4 | Almond IgE Ab [Units/volume] in Serum |
52 | 1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
53 | 6771-0 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry |
54 | 1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma |
55 | 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
56 | 19171-8 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
57 | 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
58 | 48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
59 | 53962-7 | Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
60 | 6020-2 | Alternaria alternata IgE Ab [Units/volume] in Serum |
61 | 5574-9 | Aluminum [Mass/volume] in Serum or Plasma |
62 | 6038-4 | American Beech IgE Ab [Units/volume] in Serum |
63 | 30170-5 | American Cockroach IgE Ab [Units/volume] in Serum |
64 | 6095-4 | American house dust mite IgE Ab [Units/volume] in Serum |
65 | 6263-8 | American Sycamore IgE Ab [Units/volume] in Serum |
66 | 3321-7 | Amikacin [Mass/volume] in Serum or Plasma --trough |
67 | 35083-5 | Amino acids panel [Moles/volume] - Serum or Plasma |
68 | 55152-3 | Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma |
69 | 22763-7 | Ammonia [Mass/volume] in Plasma |
70 | 16362-6 | Ammonia [Moles/volume] in Plasma |
71 | 19343-3 | Amphetamine [Presence] in Urine by Screen method |
72 | 8150-5 | Amphetamines [Mass/volume] in Urine |
73 | 8144-8 | Amphetamines [Presence] in Meconium |
74 | 8146-3 | Amphetamines [Presence] in Meconium by Screen method |
75 | 8149-7 | Amphetamines [Presence] in Serum or Plasma by Screen method |
76 | 3349-8 | Amphetamines [Presence] in Urine |
77 | 19261-7 | Amphetamines [Presence] in Urine by Screen method |
78 | 43983-6 | Amphetamines [Presence] in Urine by Screen method >500 ng/mL |
79 | 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid |
80 | 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma |
81 | 33915-0 | Anabasine [Mass/volume] in Urine |
82 | 23877-4 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
83 | 23878-2 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
84 | 1848-1 | Androstanolone [Mass/volume] in Serum or Plasma |
85 | 1854-9 | Androstenedione [Mass/volume] in Serum or Plasma |
86 | 1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
87 | 12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
88 | 2742-5 | Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
89 | 3174-0 | Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method |
90 | 27811-9 | Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
91 | 3175-7 | Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
92 | 27812-7 | Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
93 | 21619-2 | APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
94 | 1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
95 | 55724-9 | Apolipoprotein A-I and A-II and B and C panel [Mass/volume] - Serum or Plasma |
96 | 1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma |
97 | 1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
98 | 1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
99 | 6021-0 | Apple IgE Ab [Units/volume] in Serum |
100 | 3173-2 | aPTT in Blood by Coagulation assay |
101 | 49058-1 | aPTT in Blood drawn from CRRT circuit by Coagulation assay |
102 | 14979-9 | aPTT in Platelet poor plasma by Coagulation assay |
103 | 3282-1 | aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay |
104 | 61430-5 | Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay |
105 | 5583-0 | Arsenic [Mass/volume] in Blood |
106 | 54454-4 | Arsenic fractions panel - Urine |
107 | 1903-4 | Ascorbate [Mass/volume] in Serum or Plasma |
108 | 14622-5 | Ascorbate [Moles/volume] in Serum or Plasma |
109 | 1920-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
110 | 9490-4 | Aspergillus flavus Ab [Presence] in Serum |
111 | 9632-1 | Aspergillus fumigatus Ab [Presence] in Serum |
112 | 6025-1 | Aspergillus fumigatus IgE Ab [Units/volume] in Serum |
113 | 22086-3 | Aspergillus niger Ab [Presence] in Serum |
114 | 5052-6 | Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) |
115 | 5053-4 | Aspergillus sp Ab [Titer] in Serum by Complement fixation |
116 | 6029-3 | Aureobasidium pullulans IgE Ab [Units/volume] in Serum |
117 | 16117-4 | Babesia microti IgG Ab [Titer] in Serum |
118 | 16118-2 | Babesia microti IgM Ab [Titer] in Serum |
119 | 44023-0 | Bacteria [Presence] in Vaginal fluid by Wet preparation |
120 | 595-9 | Bacteria identified in Abscess by Aerobe culture |
121 | 600-7 | Bacteria identified in Blood by Culture |
122 | 610-6 | Bacteria identified in Body fluid by Aerobe culture |
123 | 611-4 | Bacteria identified in Body fluid by Culture |
124 | 19126-2 | Bacteria identified in Bone marrow by Aerobe culture |
125 | 43441-5 | Bacteria identified in Bronchoalveolar lavage by Aerobe culture |
126 | 19128-8 | Bacteria identified in Catheter tip by Culture |
127 | 606-4 | Bacteria identified in Cerebral spinal fluid by Culture |
128 | 9822-8 | Bacteria identified in Dialysis fluid by Culture |
129 | 608-0 | Bacteria identified in Ear by Aerobe culture |
130 | 609-8 | Bacteria identified in Eye by Aerobe culture |
131 | 10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
132 | 42803-7 | Bacteria identified in Isolate |
133 | 10353-1 | Bacteria identified in Nose by Aerobe culture |
134 | 619-7 | Bacteria identified in Peritoneal fluid by Culture |
135 | 634-6 | Bacteria identified in Specimen by Aerobe culture |
136 | 635-3 | Bacteria identified in Specimen by Anaerobe culture |
137 | 21020-3 | Bacteria identified in Specimen by Anaerobe+Aerobe culture |
138 | 6463-4 | Bacteria identified in Specimen by Culture |
139 | 32355-0 | Bacteria identified in Specimen by Respiratory culture |
140 | 6460-0 | Bacteria identified in Sputum by Culture |
141 | 623-9 | Bacteria identified in Sputum by Cystic fibrosis respiratory culture |
142 | 624-7 | Bacteria identified in Sputum by Respiratory culture |
143 | 625-4 | Bacteria identified in Stool by Culture |
144 | 621-3 | Bacteria identified in Synovial fluid by Culture |
145 | 17898-8 | Bacteria identified in Throat by Aerobe culture |
146 | 626-2 | Bacteria identified in Throat by Culture |
147 | 627-0 | Bacteria identified in Tissue by Aerobe culture |
148 | 20474-3 | Bacteria identified in Tissue by Biopsy culture |
149 | 630-4 | Bacteria identified in Urine by Culture |
150 | 11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture |
151 | 6462-6 | Bacteria identified in Wound by Culture |
152 | 43407-6 | Bacteria identified in Wound deep by Culture |
153 | 41477-1 | Bacterial sialidase [Presence] in Specimen |
154 | 54145-8 | Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification |
155 | 6034-3 | Bahia grass IgE Ab [Units/volume] in Serum |
156 | 31032-6 | Baker's yeast IgA Ab [Units/volume] in Serum |
157 | 47320-7 | Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay |
158 | 6287-7 | Baker's yeast IgE Ab [Units/volume] in Serum |
159 | 35538-8 | Baker's yeast IgG Ab [Mass/volume] in Serum |
160 | 6035-0 | Banana IgE Ab [Units/volume] in Serum |
161 | 9426-8 | Barbiturates [Mass/volume] in Urine |
162 | 3376-1 | Barbiturates [Presence] in Serum, Plasma or Blood |
163 | 3377-9 | Barbiturates [Presence] in Urine |
164 | 19270-8 | Barbiturates [Presence] in Urine by Screen method |
165 | 6037-6 | Barley IgE Ab [Units/volume] in Serum |
166 | 9360-9 | Bartonella quintana IgG Ab [Titer] in Serum |
167 | 9361-7 | Bartonella quintana IgM Ab [Titer] in Serum |
168 | 24321-2 | Basic metabolic 2000 panel - Serum or Plasma |
169 | 7124-1 | Bayberry Pollen IgE Ab [Units/volume] in Serum |
170 | 6039-2 | Beef IgE Ab [Units/volume] in Serum |
171 | 9428-4 | Benzodiazepines [Mass/volume] in Urine |
172 | 3389-4 | Benzodiazepines [Presence] in Serum or Plasma |
173 | 3390-2 | Benzodiazepines [Presence] in Urine |
174 | 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method |
175 | 14316-4 | Benzodiazepines [Presence] in Urine by Screen method |
176 | 70141-7 | Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL |
177 | 8187-7 | Benzoylecgonine [Presence] in Meconium |
178 | 3393-6 | Benzoylecgonine [Presence] in Urine |
179 | 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method |
180 | 43984-4 | Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL |
181 | 6041-8 | Bermuda grass IgE Ab [Units/volume] in Serum |
182 | 21108-6 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
183 | 44447-1 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
184 | 16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
185 | 44448-9 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
186 | 72488-0 | Beta 2 glycoprotein 1 IgG and IgM panel - Serum |
187 | 16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
188 | 44449-7 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
189 | 29512-1 | Beta hydroxybutyrate [Mass/volume] in Serum or Plasma |
190 | 6873-4 | Beta hydroxybutyrate [Moles/volume] in Serum or Plasma |
191 | 20423-0 | Beta lactamase organism identified in Isolate |
192 | 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
193 | 14628-2 | Bile acid [Moles/volume] in Serum or Plasma |
194 | 43130-4 | Bile acid fractions panel [Moles/volume] - Serum or Plasma |
195 | 34543-9 | Bilirubin direct and total panel [Mass/volume] - Serum or Plasma |
196 | 1968-7 | Bilirubin.direct [Mass/volume] in Serum or Plasma |
197 | 1974-5 | Bilirubin.total [Mass/volume] in Body fluid |
198 | 1975-2 | Bilirubin.total [Mass/volume] in Serum or Plasma |
199 | 1978-6 | Bilirubin.total [Mass/volume] in Urine |
200 | 1977-8 | Bilirubin.total [Presence] in Urine |
201 | 38478-4 | Biotinidase [Presence] in DBS |
202 | 41479-7 | BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
203 | 41480-5 | BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
204 | 32284-2 | BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
205 | 7816-2 | Blastomyces dermatitidis Ab [Presence] in Serum |
206 | 5057-5 | Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation |
207 | 6313-1 | Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay |
208 | 11067-6 | Bleeding time |
209 | 33720-4 | Blood bank consult |
210 | 888-8 | Blood group antibodies identified in Serum or Plasma |
211 | 14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC |
212 | 890-4 | Blood group antibody screen [Presence] in Serum or Plasma |
213 | 34532-2 | Blood type and Indirect antibody screen panel - Blood |
214 | 33721-2 | Bone marrow Pathology biopsy report |
215 | 48741-3 | Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture |
216 | 43381-3 | Bordetella pertussis Ab [Presence] in Specimen by Immunofluorescence |
217 | 550-4 | Bordetella pertussis Ag [Presence] in Specimen by Immunofluorescence |
218 | 42330-1 | Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay |
219 | 11006-4 | Borrelia burgdorferi Ab [Presence] in Serum |
220 | 20449-5 | Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
221 | 6318-0 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
222 | 4991-6 | Borrelia burgdorferi DNA [Presence] in Specimen by NAA with probe detection |
223 | 7817-0 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
224 | 5062-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay |
225 | 22131-7 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
226 | 34148-7 | Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum |
227 | 62341-3 | Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum |
228 | 5064-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay |
229 | 7155-5 | Boxelder IgE Ab [Units/volume] in Serum |
230 | 38479-2 | Branched chain keto-acid dehydrogenase complex [Presence] in DBS |
231 | 6050-9 | Brazil Nut IgE Ab [Units/volume] in Serum |
232 | 3414-0 | Buprenorphine [Presence] in Urine |
233 | 1986-9 | C peptide [Mass/volume] in Serum or Plasma |
234 | 1988-5 | C reactive protein [Mass/volume] in Serum or Plasma |
235 | 30522-7 | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
236 | 11039-5 | C reactive protein [Presence] in Serum or Plasma |
237 | 5609-3 | Cadmium [Mass/volume] in Blood |
238 | 3422-3 | Caffeine [Mass/volume] in Serum or Plasma |
239 | 49590-3 | Calcidiol and Calciferol panel - Serum or Plasma |
240 | 2236-8 | Calciferol (Vit D2) [Mass/volume] in Serum or Plasma |
241 | 1992-7 | Calcitonin [Mass/volume] in Serum or Plasma |
242 | 1649-3 | Calcitriol [Mass/volume] in Serum or Plasma |
243 | 18488-7 | Calcium [Mass/volume] in 24 hour Urine |
244 | 49765-1 | Calcium [Mass/volume] in Blood |
245 | 17861-6 | Calcium [Mass/volume] in Serum or Plasma |
246 | 17862-4 | Calcium [Mass/volume] in Urine |
247 | 35675-8 | Calcium [Mass/volume] in Urine collected for unspecified duration |
248 | 38230-9 | Calcium.ionized [Mass/volume] in Blood |
249 | 17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma |
250 | 17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
251 | 1994-3 | Calcium.ionized [Moles/volume] in Blood |
252 | 1995-0 | Calcium.ionized [Moles/volume] in Serum or Plasma |
253 | 49255-3 | Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy |
254 | 6274-5 | California Walnut IgE Ab [Units/volume] in Serum |
255 | 38445-3 | Calprotectin [Mass/mass] in Stool |
256 | 6331-3 | Campylobacter sp identified in Stool by Organism specific culture |
257 | 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma |
258 | 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
259 | 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
260 | 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
261 | 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
262 | 6059-0 | Candida albicans IgE Ab [Units/volume] in Serum |
263 | 35270-8 | Candida sp Ab [Presence] in Serum by Immune diffusion (ID) |
264 | 47000-5 | Candida sp rRNA [Presence] in Vaginal fluid by Probe |
265 | 42860-7 | Cannabinoids [Mass/volume] in Urine |
266 | 31080-5 | Cannabinoids [Presence] in Meconium by Screen method |
267 | 18282-4 | Cannabinoids [Presence] in Urine by Screen method |
268 | 70145-8 | Cannabinoids [Presence] in Urine by Screen method >50 ng/mL |
269 | 3432-2 | carBAMazepine [Mass/volume] in Serum or Plasma |
270 | 2028-9 | Carbon dioxide, total [Moles/volume] in Serum or Plasma |
271 | 3436-3 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine |
272 | 20521-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
273 | 20563-3 | Carboxyhemoglobin/Hemoglobin.total in Blood |
274 | 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
275 | 5076-5 | Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay |
276 | 45057-7 | Cardiolipin IgA and IgG and IgM panel - Serum |
277 | 3181-5 | Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay |
278 | 24319-6 | Cardiolipin IgG and IgM panel - Serum |
279 | 3182-3 | Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay |
280 | 2053-7 | Carotene [Mass/volume] in Serum or Plasma |
281 | 6061-6 | Carrot IgE Ab [Units/volume] in Serum |
282 | 6062-4 | Casein IgE Ab [Units/volume] in Serum |
283 | 53829-8 | Casein IgG Ab [Mass/volume] in Serum |
284 | 6718-1 | Cashew nut IgE Ab [Units/volume] in Serum |
285 | 6833-8 | Cat dander IgE Ab [Units/volume] in Serum |
286 | 73879-9 | Catecholamine metabolites and creatinine panel - Urine |
287 | 58410-2 | CBC panel - Blood by Automated count |
288 | 57021-8 | CBC W Auto Differential panel - Blood |
289 | 69742-5 | CBC W Differential panel, method unspecified - Blood |
290 | 57782-5 | CBC W Ordered Manual Differential panel - Blood |
291 | 57022-6 | CBC W Reflex Manual Differential panel - Blood |
292 | 34557-9 | Cell count and Differential panel - Body fluid |
293 | 34564-5 | Cell count and Differential panel - Cerebral spinal fluid |
294 | 34556-1 | Cell count panel - Body fluid |
295 | 34563-7 | Cell count panel - Cerebral spinal fluid |
296 | 8068-9 | Centromere Ab [Units/volume] in Serum |
297 | 53982-5 | Centromere protein B Ab [Units/volume] in Serum |
298 | 2064-4 | Ceruloplasmin [Mass/volume] in Serum or Plasma |
299 | 21654-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
300 | 38404-0 | CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
301 | 19734-3 | Chicken droppings IgE Ab [Units/volume] in Serum |
302 | 6070-7 | Chicken feather IgE Ab [Units/volume] in Serum |
303 | 6071-5 | Chicken meat IgE Ab [Units/volume] in Serum |
304 | 560-3 | Chlamydia sp identified in Specimen by Organism specific culture |
305 | 6349-5 | Chlamydia trachomatis [Presence] in Specimen by Organism specific culture |
306 | 36903-3 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection |
307 | 64017-7 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Specimen by NAA with probe detection |
308 | 21190-4 | Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection |
309 | 21613-5 | Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection |
310 | 6357-8 | Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection |
311 | 50387-0 | Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection |
312 | 43304-5 | Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection |
313 | 4993-2 | Chlamydia trachomatis rRNA [Presence] in Specimen by Probe |
314 | 53925-4 | Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection |
315 | 42931-6 | Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection |
316 | 21184-7 | Chlamydophila pneumoniae [Presence] in Specimen by Organism specific culture |
317 | 2069-3 | Chloride [Moles/volume] in Blood |
318 | 2075-0 | Chloride [Moles/volume] in Serum or Plasma |
319 | 2077-6 | Chloride [Moles/volume] in Sweat |
320 | 2078-4 | Chloride [Moles/volume] in Urine |
321 | 35676-6 | Chloride [Moles/volume] in Urine collected for unspecified duration |
322 | 6073-1 | Chocolate IgE Ab [Units/volume] in Serum |
323 | 1990-1 | Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
324 | 2093-3 | Cholesterol [Mass/volume] in Serum or Plasma |
325 | 2085-9 | Cholesterol in HDL [Mass/volume] in Serum or Plasma |
326 | 2089-1 | Cholesterol in LDL [Mass/volume] in Serum or Plasma |
327 | 18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
328 | 35558-6 | Cholinesterase panel [Enzymatic activity/volume] - Blood |
329 | 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
330 | 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine |
331 | 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma |
332 | 25372-4 | Choriogonadotropin [Units/volume] in Urine |
333 | 2110-5 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
334 | 2112-1 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
335 | 2111-3 | Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
336 | 2114-7 | Choriogonadotropin.beta subunit [Moles/volume] in Urine |
337 | 43799-6 | Choriogonadotropin.beta subunit [Presence] in Specimen |
338 | 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
339 | 2115-4 | Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
340 | 30243-0 | Choriogonadotropin.intact [Units/volume] in Serum or Plasma |
341 | 45194-8 | Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma |
342 | 53959-3 | Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma |
343 | 51775-5 | Chromatin Ab [Units/volume] in Serum or Plasma |
344 | 5619-2 | Chromium [Mass/volume] in Blood |
345 | 5622-6 | Chromium [Mass/volume] in Serum or Plasma |
346 | 9811-1 | Chromogranin A [Mass/volume] in Serum or Plasma |
347 | 25587-7 | Chromogranin A [Moles/volume] in Serum or Plasma |
348 | 30169-7 | Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay |
349 | 50659-2 | Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative |
350 | 45269-8 | Chronic leukemia panel - Specimen by Flow cytometry (FC) |
351 | 20640-9 | Citrulline [Moles/volume] in Serum or Plasma |
352 | 6075-6 | Cladosporium herbarum IgE Ab [Units/volume] in Serum |
353 | 7415-3 | Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum |
354 | 6076-4 | Clam IgE Ab [Units/volume] in Serum |
355 | 35603-0 | clonazePAM [Mass/volume] in Serum or Plasma by Screen method |
356 | 34712-0 | Clostridioides difficile [Presence] in Stool |
357 | 20761-3 | Clostridioides difficile [Presence] in Stool by Agglutination |
358 | 61367-9 | Clostridioides difficile DNA [Presence] in Specimen by NAA with probe detection |
359 | 34713-8 | Clostridioides difficile toxin A+B [Presence] in Stool |
360 | 6362-8 | Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay |
361 | 34468-9 | Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay |
362 | 54067-4 | Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection |
363 | 22203-4 | Clostridium tetani IgG Ab [Units/volume] in Serum |
364 | 6367-7 | Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay |
365 | 6896-5 | cloZAPine [Mass/volume] in Serum or Plasma |
366 | 65632-2 | cloZAPine and Norclozapine panel - Serum or Plasma |
367 | 3187-2 | Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay |
368 | 3193-0 | Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay |
369 | 3198-9 | Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay |
370 | 3209-4 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay |
371 | 3218-5 | Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay |
372 | 3226-8 | Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay |
373 | 16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood |
374 | 2132-9 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma |
375 | 5625-9 | Cobalt [Mass/volume] in Blood |
376 | 5627-5 | Cobalt [Mass/volume] in Serum or Plasma |
377 | 40527-4 | Cocaine [Presence] in Meconium |
378 | 8191-9 | Cocaine [Presence] in Serum or Plasma by Screen method |
379 | 3397-7 | Cocaine [Presence] in Urine |
380 | 53743-1 | Cocaine metabolites.other [Mass/volume] in Urine |
381 | 5095-5 | Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) |
382 | 5096-3 | Coccidioides immitis Ab [Titer] in Serum by Complement fixation |
383 | 13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
384 | 13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
385 | 6078-0 | Cockroach IgE Ab [Units/volume] in Serum |
386 | 24139-8 | Cockroach IgG Ab [Units/volume] in Serum |
387 | 6195-2 | Cocksfoot IgE Ab [Units/volume] in Serum |
388 | 6081-4 | Coconut IgE Ab [Units/volume] in Serum |
389 | 16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method |
390 | 3507-1 | Codeine [Presence] in Urine |
391 | 6082-2 | Codfish IgE Ab [Units/volume] in Serum |
392 | 27923-2 | Coenzyme Q10 [Mass/volume] in Serum or Plasma |
393 | 5098-9 | Cold agglutinin [Titer] in Serum or Plasma by Agglutination |
394 | 41171-0 | Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma |
395 | 21215-9 | Collagen crosslinked N-telopeptide [Moles/volume] in Serum |
396 | 27939-8 | Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
397 | 14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
398 | 7604-2 | Common Pigweed IgE Ab [Units/volume] in Serum |
399 | 6085-5 | Common Ragweed IgE Ab [Units/volume] in Serum |
400 | 4477-6 | Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma |
401 | 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
402 | 4485-9 | Complement C3 [Mass/volume] in Serum or Plasma |
403 | 34544-7 | Complement C3 and C4 panel [Mass/volume] - Serum or Plasma |
404 | 4498-2 | Complement C4 [Mass/volume] in Serum or Plasma |
405 | 4532-8 | Complement total hemolytic CH50 [Units/volume] in Serum or Plasma |
406 | 24323-8 | Comprehensive metabolic 2000 panel - Serum or Plasma |
407 | 5631-7 | Copper [Mass/volume] in Serum or Plasma |
408 | 51662-5 | Core respiratory allergens panel - Serum |
409 | 6087-1 | Corn IgE Ab [Units/volume] in Serum |
410 | 2141-0 | Corticotropin [Mass/volume] in Plasma |
411 | 2142-8 | Cortisol [Mass/volume] in Saliva (oral fluid) |
412 | 2143-6 | Cortisol [Mass/volume] in Serum or Plasma |
413 | 9813-7 | Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen |
414 | 9812-9 | Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen |
415 | 2147-7 | Cortisol Free [Mass/time] in 24 hour Urine |
416 | 2145-1 | Cortisol Free [Mass/volume] in Serum or Plasma |
417 | 11040-3 | Cortisol Free [Mass/volume] in Urine |
418 | 5116-9 | Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay |
419 | 13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
420 | 58787-3 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay |
421 | 10366-3 | Cotinine [Mass/volume] in Urine |
422 | 12293-7 | Cotinine [Presence] in Urine |
423 | 6090-5 | Cottonwood IgE Ab [Units/volume] in Serum |
424 | 7258-7 | Cow milk IgE Ab [Units/volume] in Serum |
425 | 56234-8 | Cow milk IgG4 Ab [Mass/volume] in Serum |
426 | 7774-3 | Cow whey IgE Ab [Units/volume] in Serum |
427 | 41840-0 | Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum |
428 | 41484-7 | Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation |
429 | 41485-4 | Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation |
430 | 6092-1 | Crab IgE Ab [Units/volume] in Serum |
431 | 2157-6 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
432 | 32673-6 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma |
433 | 49551-5 | Creatine kinase.MB [Mass/volume] in Blood |
434 | 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
435 | 20624-3 | Creatinine [Mass/volume] in 24 hour Urine |
436 | 2159-2 | Creatinine [Mass/volume] in Amniotic fluid |
437 | 38483-4 | Creatinine [Mass/volume] in Blood |
438 | 12190-5 | Creatinine [Mass/volume] in Body fluid |
439 | 2160-0 | Creatinine [Mass/volume] in Serum or Plasma |
440 | 2161-8 | Creatinine [Mass/volume] in Urine |
441 | 35674-1 | Creatinine [Mass/volume] in Urine collected for unspecified duration |
442 | 65634-8 | Creatinine 24 hour urine panel - 24 hour Urine |
443 | 58446-6 | Creatinine 24H renal clearance adjusted for body surface area panel |
444 | 34555-3 | Creatinine 24H renal clearance panel |
445 | 45066-8 | Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood |
446 | 11043-7 | Cryofibrinogen [Presence] in Plasma |
447 | 5117-7 | Cryoglobulin [Presence] in Serum |
448 | 31788-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid |
449 | 29533-7 | Cryptococcus sp Ag [Presence] in Specimen |
450 | 9820-2 | Cryptococcus sp Ag [Titer] in Serum by Latex agglutination |
451 | 41487-0 | Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
452 | 20781-1 | Cryptosporidium sp [Presence] in Stool by Acid fast stain |
453 | 6371-9 | Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
454 | 6372-7 | Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence |
455 | 6825-4 | Crystals [type] in Body fluid by Light microscopy |
456 | 5781-0 | Crystals [type] in Synovial fluid by Light microscopy |
457 | 32218-0 | Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay |
458 | 57093-7 | Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
459 | 33935-8 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma |
460 | 3520-4 | cycloSPORINE [Mass/volume] in Blood |
461 | 32997-9 | cycloSPORINE [Mass/volume] in Blood --2 hours post dose |
462 | 33863-2 | Cystatin C [Mass/volume] in Serum or Plasma |
463 | 54078-1 | Cystic fibrosis newborn screening panel |
464 | 47528-5 | Cytology report of Cervical or vaginal smear or scraping Cyto stain |
465 | 47527-7 | Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep |
466 | 33718-8 | Cytology report of Tissue fine needle aspirate Cyto stain |
467 | 5838-8 | Cytomegalovirus [Presence] in Specimen by Organism specific culture |
468 | 31797-4 | Cytomegalovirus Ag [Presence] in Specimen |
469 | 6379-2 | Cytomegalovirus Ag [Presence] in Specimen by Immunoassay |
470 | 30247-1 | Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
471 | 33006-8 | Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
472 | 28008-1 | Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification |
473 | 30246-3 | Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
474 | 5000-5 | Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection |
475 | 7852-7 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma |
476 | 5124-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
477 | 24315-4 | Cytomegalovirus IgG and IgM panel - Serum or Plasma |
478 | 24119-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
479 | 49539-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
480 | 5127-6 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
481 | 5126-8 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
482 | 2193-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma |
483 | 2196-4 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma |
484 | 2191-5 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma |
485 | 41878-0 | Dengue virus IgG and IgM panel - Serum by Immunoassay |
486 | 10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
487 | 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
488 | 11013-0 | DNA double strand Ab [Titer] in Serum |
489 | 34187-5 | DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
490 | 5130-0 | DNA double strand Ab [Units/volume] in Serum |
491 | 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
492 | 6098-8 | Dog dander IgE Ab [Units/volume] in Serum |
493 | 6099-6 | Dog epithelium IgE Ab [Units/volume] in Serum |
494 | 7287-6 | Dog Fennel IgE Ab [Units/volume] in Serum |
495 | 2218-6 | DOPamine [Mass/time] in 24 hour Urine |
496 | 2216-0 | DOPamine [Mass/volume] in Serum or Plasma |
497 | 2217-8 | DOPamine [Mass/volume] in Urine |
498 | 40464-0 | Drugs identified in Urine by Confirmatory method |
499 | 65750-2 | Drugs of abuse 5 panel - Urine by Screen method |
500 | 6303-2 | dRVVT (LA screen) |
501 | 6282-8 | Eastern White Pine IgE Ab [Units/volume] in Serum |
502 | 21665-5 | EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
503 | 6106-9 | Egg white IgE Ab [Units/volume] in Serum |
504 | 6107-7 | Egg yolk IgE Ab [Units/volume] in Serum |
505 | 9783-2 | Ehrlichia chaffeensis IgG Ab [Titer] in Serum |
506 | 45059-3 | Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence |
507 | 9784-0 | Ehrlichia chaffeensis IgM Ab [Titer] in Serum |
508 | 25907-7 | Elastase.pancreatic [Mass/mass] in Stool |
509 | 24326-1 | Electrolytes 1998 panel - Serum or Plasma |
510 | 55231-5 | Electrolytes panel - Blood |
511 | 14708-2 | Endomysium Ab [Titer] in Serum |
512 | 10362-2 | Endomysium IgA Ab [Presence] in Serum |
513 | 10863-9 | Endomysium IgA Ab [Titer] in Serum |
514 | 27038-9 | Endomysium IgA Ab [Titer] in Serum by Immunofluorescence |
515 | 20797-7 | Endotoxin identified in Specimen |
516 | 6110-1 | English plantain IgE Ab [Units/volume] in Serum |
517 | 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
518 | 9522-4 | Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay |
519 | 675-9 | Enterobius vermicularis [Presence] in Specimen by Pinworm exam |
520 | 29591-5 | Enterovirus RNA [Presence] in Specimen by NAA with probe detection |
521 | 26449-9 | Eosinophils [#/volume] in Blood |
522 | 711-2 | Eosinophils [#/volume] in Blood by Automated count |
523 | 48049-1 | Eosinophils [Presence] in Stool by Wright stain |
524 | 49839-4 | Eosinophils [Presence] in Urine sediment by Wright stain |
525 | 12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count |
526 | 30339-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum |
527 | 24114-1 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
528 | 40750-2 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence |
529 | 5158-1 | Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence |
530 | 7885-7 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum |
531 | 5157-3 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay |
532 | 24316-2 | Epstein Barr virus capsid IgG and IgM panel - Serum |
533 | 30340-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum |
534 | 24115-8 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
535 | 5160-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
536 | 7886-5 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum |
537 | 5159-9 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay |
538 | 32585-2 | Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
539 | 5005-4 | Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection |
540 | 14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
541 | 40752-8 | Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay |
542 | 24007-7 | Epstein Barr virus early IgG Ab [Units/volume] in Serum |
543 | 56598-6 | Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay |
544 | 22296-8 | Epstein Barr virus nuclear Ab [Presence] in Serum |
545 | 22297-6 | Epstein Barr virus nuclear Ab [Titer] in Serum |
546 | 21260-5 | Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
547 | 7883-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
548 | 5156-5 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay |
549 | 31374-2 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum |
550 | 30083-0 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
551 | 30341-2 | Erythrocyte sedimentation rate |
552 | 4537-7 | Erythrocyte sedimentation rate by Westergren method |
553 | 789-8 | Erythrocytes [#/volume] in Blood by Automated count |
554 | 15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
555 | 21262-1 | Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay |
556 | 2243-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma |
557 | 35384-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method |
558 | 2251-7 | Estriol (E3) [Mass/volume] in Serum or Plasma |
559 | 2250-9 | Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma |
560 | 2254-1 | Estrogen [Mass/volume] in Serum or Plasma |
561 | 53766-2 | Estrogen fraction panel - Serum or Plasma |
562 | 2258-2 | Estrone (E1) [Mass/volume] in Serum or Plasma |
563 | 5640-8 | Ethanol [Mass/volume] in Blood |
564 | 5643-2 | Ethanol [Mass/volume] in Serum or Plasma |
565 | 5645-7 | Ethanol [Mass/volume] in Urine |
566 | 5639-0 | Ethanol [Presence] in Blood |
567 | 5644-0 | Ethanol [Presence] in Urine |
568 | 3616-0 | Ethosuximide [Mass/volume] in Serum or Plasma |
569 | 45324-1 | Ethyl glucuronide [Mass/volume] in Urine |
570 | 58375-7 | Ethyl glucuronide [Presence] in Urine by Screen method |
571 | 5646-5 | Ethylene glycol [Mass/volume] in Serum, Plasma or Blood |
572 | 6096-2 | European house dust mite IgE Ab [Units/volume] in Serum |
573 | 50544-6 | Everolimus [Mass/volume] in Blood |
574 | 24475-6 | F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
575 | 24476-4 | F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
576 | 21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
577 | 1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma |
578 | 16142-2 | Fat [Mass/time] in 24 hour Stool |
579 | 2270-7 | Fat [Presence] in Stool |
580 | 12598-9 | Fat.neutral [Presence] in Stool |
581 | 11235-9 | fentaNYL [Presence] in Urine |
582 | 2276-4 | Ferritin [Mass/volume] in Serum or Plasma |
583 | 29280-5 | Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination |
584 | 48066-5 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma |
585 | 48058-2 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay |
586 | 48065-7 | Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma |
587 | 3255-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay |
588 | 3256-5 | Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
589 | 48039-2 | Fibronectin.fetal [Presence] in Specimen |
590 | 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid |
591 | 48798-3 | First trimester maternal screen panel - Serum or Plasma |
592 | 33719-6 | Flow cytometry study |
593 | 21759-6 | FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
594 | 36913-2 | FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
595 | 2282-2 | Folate [Mass/volume] in Blood |
596 | 2283-0 | Folate [Mass/volume] in Red Blood Cells |
597 | 2284-8 | Folate [Mass/volume] in Serum or Plasma |
598 | 15067-2 | Follitropin [Units/volume] in Serum or Plasma |
599 | 34549-6 | Follitropin and Lutropin panel [Units/volume] - Serum or Plasma |
600 | 15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
601 | 49222-3 | Food allergen panel - Serum |
602 | 21760-4 | FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
603 | 721-1 | Free Hemoglobin [Mass/volume] in Plasma |
604 | 4635-9 | Free Hemoglobin [Mass/volume] in Serum |
605 | 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma |
606 | 13943-6 | Fructose [Presence] in Semen |
607 | 56146-4 | Fungal Ab panel - Serum |
608 | 601-5 | Fungus identified in Blood by Culture |
609 | 15378-3 | Fungus identified in Isolate by Culture |
610 | 575-1 | Fungus identified in Skin by Culture |
611 | 580-1 | Fungus identified in Specimen by Culture |
612 | 21003-9 | Fungus identified in Specimen by Fungus stain |
613 | 6121-8 | Fusarium moniliforme IgE Ab [Units/volume] in Serum |
614 | 9738-6 | Gabapentin [Mass/volume] in Serum, Plasma or Blood |
615 | 44099-0 | Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay |
616 | 35383-9 | Galactomannan Ag [Units/volume] in Serum or Plasma |
617 | 44357-2 | Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay |
618 | 62419-7 | Galectin 3 [Mass/volume] in Serum or Plasma |
619 | 2324-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
620 | 6410-5 | Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe |
621 | 2333-3 | Gastrin [Mass/volume] in Serum or Plasma |
622 | 35668-3 | Gentamicin [Mass/volume] in Serum or Plasma |
623 | 3663-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak |
624 | 3665-7 | Gentamicin [Mass/volume] in Serum or Plasma --trough |
625 | 6412-1 | Giardia lamblia Ag [Presence] in Stool by Immunoassay |
626 | 48060-8 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool |
627 | 7893-1 | Gliadin Ab [Units/volume] in Serum |
628 | 6924-5 | Gliadin IgA Ab [Units/volume] in Serum |
629 | 20495-8 | Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
630 | 5170-6 | Gliadin IgG Ab [Units/volume] in Serum |
631 | 20496-6 | Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
632 | 30343-8 | Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
633 | 2339-0 | Glucose [Mass/volume] in Blood |
634 | 2344-0 | Glucose [Mass/volume] in Body fluid |
635 | 32016-8 | Glucose [Mass/volume] in Capillary blood |
636 | 41653-7 | Glucose [Mass/volume] in Capillary blood by Glucometer |
637 | 2342-4 | Glucose [Mass/volume] in Cerebral spinal fluid |
638 | 2345-7 | Glucose [Mass/volume] in Serum or Plasma |
639 | 1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
640 | 1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
641 | 20438-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
642 | 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
643 | 12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
644 | 1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
645 | 1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
646 | 20436-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
647 | 1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
648 | 2350-7 | Glucose [Mass/volume] in Urine |
649 | 5792-7 | Glucose [Mass/volume] in Urine by Test strip |
650 | 2349-9 | Glucose [Presence] in Urine |
651 | 25428-4 | Glucose [Presence] in Urine by Test strip |
652 | 24353-5 | Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma |
653 | 50608-9 | Glucose tolerance 3 hours gestational panel - Serum or Plasma |
654 | 32546-4 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
655 | 2357-2 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
656 | 2356-4 | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
657 | 13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
658 | 56540-8 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay |
659 | 6125-9 | Gluten IgE Ab [Units/volume] in Serum |
660 | 63091-3 | Gluten IgG Ab [Mass/volume] in Serum |
661 | 6129-1 | Goose feather IgE Ab [Units/volume] in Serum |
662 | 6156-4 | Goosefoot IgE Ab [Units/volume] in Serum |
663 | 15284-3 | Grey Alder IgE Ab [Units/volume] in Serum |
664 | 7110-0 | Groundsel Tree IgE Ab [Units/volume] in Serum |
665 | 6113-5 | Gum-Tree IgE Ab [Units/volume] in Serum |
666 | 29559-2 | Haemophilus ducreyi DNA [Presence] in Specimen by NAA with probe detection |
667 | 11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
668 | 4542-7 | Haptoglobin [Mass/volume] in Serum or Plasma |
669 | 6136-6 | Hazelnut IgE Ab [Units/volume] in Serum |
670 | 6137-4 | Hazelnut Pollen IgE Ab [Units/volume] in Serum |
671 | 21687-9 | HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
672 | 29588-1 | Heavy metals panel - Blood |
673 | 29891-9 | Helicobacter pylori [Presence] in Stomach by urea breath test |
674 | 22310-7 | Helicobacter pylori Ab [Presence] in Serum |
675 | 7900-4 | Helicobacter pylori Ab [Units/volume] in Serum |
676 | 31843-6 | Helicobacter pylori Ag [Presence] in Stool |
677 | 17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
678 | 7901-2 | Helicobacter pylori IgA Ab [Units/volume] in Serum |
679 | 6420-4 | Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay |
680 | 16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum |
681 | 17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
682 | 7902-0 | Helicobacter pylori IgG Ab [Units/volume] in Serum |
683 | 5176-3 | Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay |
684 | 5177-1 | Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay |
685 | 20570-8 | Hematocrit [Volume Fraction] of Blood |
686 | 11153-4 | Hematocrit [Volume Fraction] of Body fluid |
687 | 718-7 | Hemoglobin [Mass/volume] in Blood |
688 | 48035-0 | Hemoglobin [Presence] in Cerebral spinal fluid |
689 | 17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
690 | 24360-0 | Hemoglobin and Hematocrit panel - Blood |
691 | 32140-6 | Hemoglobin F [Presence] in Blood by Kleihauer-Betke method |
692 | 4621-9 | Hemoglobin S [Presence] in Blood |
693 | 6864-3 | Hemoglobin S [Presence] in Blood by Solubility test |
694 | 4625-0 | Hemoglobin S/Hemoglobin.total in Blood |
695 | 2334-1 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
696 | 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool |
697 | 29771-3 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay |
698 | 34701-3 | Heparin induced platelet Ab [Presence] in Serum |
699 | 3274-8 | Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method |
700 | 24325-3 | Hepatic function 2000 panel - Serum or Plasma |
701 | 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
702 | 5183-9 | Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay |
703 | 22314-9 | Hepatitis A virus IgM Ab [Presence] in Serum |
704 | 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
705 | 22315-6 | Hepatitis A virus IgM Ab [Units/volume] in Serum |
706 | 5181-3 | Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay |
707 | 16933-4 | Hepatitis B virus core Ab [Presence] in Serum |
708 | 47440-3 | Hepatitis B virus core Ab [Presence] in Serum from Donor |
709 | 13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
710 | 5187-0 | Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay |
711 | 31204-1 | Hepatitis B virus core IgM Ab [Presence] in Serum |
712 | 24113-3 | Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay |
713 | 5185-4 | Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
714 | 29615-2 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
715 | 11258-1 | Hepatitis B virus DNA [Units/volume] in Serum |
716 | 13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
717 | 31844-4 | Hepatitis B virus e Ag [Presence] in Serum |
718 | 13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
719 | 5191-2 | Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay |
720 | 22322-2 | Hepatitis B virus surface Ab [Presence] in Serum |
721 | 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
722 | 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
723 | 5194-6 | Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
724 | 5193-8 | Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay |
725 | 5195-3 | Hepatitis B virus surface Ag [Presence] in Serum |
726 | 47364-5 | Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay |
727 | 5196-1 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay |
728 | 7905-3 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test |
729 | 16128-1 | Hepatitis C virus Ab [Presence] in Serum |
730 | 5199-5 | Hepatitis C virus Ab [Presence] in Serum by Immunoblot |
731 | 47441-1 | Hepatitis C virus Ab [Presence] in Serum from Donor |
732 | 13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
733 | 5198-7 | Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay |
734 | 48159-8 | Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
735 | 49846-9 | Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor |
736 | 32286-7 | Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
737 | 20416-4 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
738 | 47252-2 | Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
739 | 38180-6 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
740 | 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
741 | 11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
742 | 22330-5 | Hepatitis D virus Ab [Units/volume] in Serum |
743 | 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum |
744 | 51916-5 | Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
745 | 5206-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay |
746 | 50758-2 | Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence |
747 | 20444-6 | Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection |
748 | 49848-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot |
749 | 27948-9 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay |
750 | 41399-7 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay |
751 | 17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum |
752 | 43180-9 | Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
753 | 5209-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
754 | 26927-4 | Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence |
755 | 5202-7 | Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay |
756 | 62454-4 | Herpes simplex virus and Varicella zoster virus identified in Specimen by Organism specific culture |
757 | 5856-0 | Herpes simplex virus identified in Genital specimen by Organism specific culture |
758 | 5859-4 | Herpes simplex virus identified in Specimen by Organism specific culture |
759 | 35423-3 | Herpes simplex virus identified in Vaginal fluid by Organism specific culture |
760 | 25435-9 | Herpes simplex virus IgM Ab [Presence] in Serum |
761 | 40729-6 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay |
762 | 5211-8 | Herpes virus 6 IgG Ab [Units/volume] in Serum |
763 | 31418-7 | Heterophile Ab [Presence] in Serum |
764 | 5213-4 | Heterophile Ab [Presence] in Serum by Latex agglutination |
765 | 32632-2 | HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
766 | 21694-5 | HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
767 | 34519-9 | HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
768 | 21695-2 | HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method |
769 | 29996-6 | Histone IgG Ab [Units/volume] in Serum by Immunoassay |
770 | 5218-3 | Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
771 | 19108-0 | Histoplasma capsulatum Ag [Presence] in Serum |
772 | 44525-4 | Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay |
773 | 6428-7 | Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay |
774 | 19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
775 | 44528-8 | Histoplasma capsulatum M Ab [Presence] in Serum |
776 | 7917-8 | HIV 1 Ab [Presence] in Serum |
777 | 29893-5 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay |
778 | 5221-7 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot |
779 | 24012-7 | HIV 1 Ag [Presence] in Serum |
780 | 5222-5 | HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay |
781 | 20447-9 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
782 | 25836-8 | HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
783 | 29539-4 | HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification |
784 | 29541-0 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
785 | 25835-0 | HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection |
786 | 23876-6 | HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification |
787 | 7918-6 | HIV 1+2 Ab [Presence] in Serum |
788 | 44533-8 | HIV 1+2 Ab [Presence] in Serum from Donor |
789 | 31201-7 | HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay |
790 | 49580-4 | HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay |
791 | 22357-8 | HIV 1+2 Ab [Units/volume] in Serum |
792 | 48345-3 | HIV 1+O+2 Ab [Presence] in Serum or Plasma |
793 | 48346-1 | HIV 1+O+2 Ab [Units/volume] in Serum or Plasma |
794 | 5225-8 | HIV 2 Ab [Presence] in Serum by Immunoblot |
795 | 30361-0 | HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay |
796 | 49573-9 | HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
797 | 33630-5 | HIV protease gene mutations detected [Identifier] |
798 | 46994-0 | HLA-A+B+C (class I) Ab in Serum |
799 | 42358-2 | HLA-B*57:01 [Presence] in Specimen |
800 | 4821-5 | HLA-B27 [Presence] |
801 | 26028-1 | HLA-B27 [Presence] by Flow cytometry (FC) |
802 | 26043-0 | HLA-B27 [Presence] by NAA with probe detection |
803 | 2428-1 | Homocysteine [Mass/volume] in Serum or Plasma |
804 | 13965-9 | Homocysteine [Moles/volume] in Serum or Plasma |
805 | 38486-7 | Homocystine [Presence] in DBS |
806 | 6844-5 | Honey bee IgE Ab [Units/volume] in Serum |
807 | 6143-2 | Horse dander IgE Ab [Units/volume] in Serum |
808 | 9828-5 | House dust Greer IgE Ab [Units/volume] in Serum |
809 | 22070-7 | HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
810 | 22362-8 | HTLV I+II Ab [Presence] in Serum |
811 | 29901-6 | HTLV I+II Ab [Presence] in Serum by Immunoassay |
812 | 16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot |
813 | 44538-7 | HTLV I+II Ab [Presence] in Serum from Donor |
814 | 55180-4 | Human epididymis protein 4 [Moles/volume] in Serum or Plasma |
815 | 71432-9 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix |
816 | 30167-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
817 | 21440-3 | Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe |
818 | 71431-1 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
819 | 21441-1 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe |
820 | 42481-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification |
821 | 44547-8 | Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification |
822 | 48560-7 | Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection |
823 | 12308-3 | HYDROcodone [Presence] in Urine |
824 | 9834-3 | HYDROmorphone [Presence] in Urine |
825 | 2458-8 | IgA [Mass/volume] in Serum or Plasma |
826 | 2460-4 | IgD [Mass/volume] in Serum |
827 | 2462-0 | IgE [Mass/volume] in Serum |
828 | 19113-0 | IgE [Units/volume] in Serum or Plasma |
829 | 2464-6 | IgG [Mass/volume] in Cerebral spinal fluid |
830 | 2465-3 | IgG [Mass/volume] in Serum or Plasma |
831 | 47289-4 | IgG and IgG subclass panel [Mass/volume] - Serum |
832 | 47290-2 | IgG subclass panel [Mass/volume] - Serum |
833 | 2472-9 | IgM [Mass/volume] in Serum or Plasma |
834 | 27831-7 | Immune complex [Units/volume] in Serum or Plasma by C1q binding assay |
835 | 49120-9 | Immunodeficiency follow-up panel - Specimen by Flow cytometry (FC) |
836 | 45268-0 | Immunodeficiency panel - Blood by Flow cytometry (FC) |
837 | 49275-1 | Immunofixation for Serum or Plasma Narrative |
838 | 13440-3 | Immunofixation for Urine |
839 | 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
840 | 43110-6 | Immunoglobulin light chains panel - 24 hour Urine |
841 | 57778-3 | Immunoglobulin light chains.free panel - Serum |
842 | 34550-4 | Immunoglobulin panel [Mass/volume] - Serum |
843 | 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
844 | 5862-8 | Influenza virus A Ag [Presence] in Specimen by Immunoassay |
845 | 5863-6 | Influenza virus A Ag [Presence] in Specimen by Immunofluorescence |
846 | 72366-8 | Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay |
847 | 48509-4 | Influenza virus A and B RNA [Identifier] in Specimen by NAA with probe detection |
848 | 31437-7 | Influenza virus A IgG Ab [Units/volume] in Serum |
849 | 24015-0 | Influenza virus A+B Ag [Presence] in Specimen |
850 | 6437-8 | Influenza virus A+B Ag [Presence] in Specimen by Immunoassay |
851 | 6438-6 | Influenza virus A+B Ag [Presence] in Specimen by Immunofluorescence |
852 | 46083-2 | Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay |
853 | 5866-9 | Influenza virus B Ag [Presence] in Specimen by Immunoassay |
854 | 17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum |
855 | 6604-3 | Influenza virus identified in Specimen by Organism specific culture |
856 | 23883-2 | Inhibin A [Mass/volume] in Serum or Plasma |
857 | 34319-4 | Inhibin B [Mass/volume] in Serum or Plasma |
858 | 20448-7 | Insulin [Units/volume] in Serum or Plasma |
859 | 8072-1 | Insulin Ab [Units/volume] in Serum |
860 | 6901-3 | Insulin Free [Units/volume] in Serum or Plasma |
861 | 48615-9 | Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma |
862 | 2483-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
863 | 2484-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
864 | 9537-2 | Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA) |
865 | 2494-3 | Iodine [Mass/volume] in Serum or Plasma |
866 | 2498-4 | Iron [Mass/volume] in Serum or Plasma |
867 | 50190-8 | Iron and Iron binding capacity panel - Serum or Plasma |
868 | 2500-7 | Iron binding capacity [Mass/volume] in Serum or Plasma |
869 | 2501-5 | Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma |
870 | 31209-0 | Islet cell 512 Ab [Units/volume] in Serum |
871 | 5669-7 | Isopropanol [Mass/volume] in Serum or Plasma |
872 | 10853-0 | Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified |
873 | 6151-5 | Italian Cypress IgE Ab [Units/volume] in Serum |
874 | 43399-5 | JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
875 | 5234-0 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay |
876 | 11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum |
877 | 6152-3 | Johnson grass IgE Ab [Units/volume] in Serum |
878 | 11050-2 | Kappa light chains [Mass/volume] in Serum or Plasma |
879 | 36916-5 | Kappa light chains.free [Mass/volume] in Serum |
880 | 33773-3 | Karyotype [Identifier] in Amniotic fluid Nominal |
881 | 29770-5 | Karyotype [Identifier] in Blood or Tissue Nominal |
882 | 33893-9 | Karyotype [Identifier] in Bone marrow Nominal |
883 | 6153-1 | Kentucky blue grass IgE Ab [Units/volume] in Serum |
884 | 33058-9 | Ketones [Mass/volume] in Serum or Plasma |
885 | 5797-6 | Ketones [Mass/volume] in Urine by Test strip |
886 | 33903-6 | Ketones [Presence] in Urine |
887 | 59297-2 | Lacosamide [Mass/volume] in Serum or Plasma |
888 | 7445-0 | Lactalbumin alpha IgE Ab [Units/volume] in Serum |
889 | 14118-4 | Lactate [Mass/volume] in Serum or Plasma |
890 | 32693-4 | Lactate [Moles/volume] in Blood |
891 | 2524-7 | Lactate [Moles/volume] in Serum or Plasma |
892 | 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
893 | 60017-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction |
894 | 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
895 | 14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
896 | 42929-0 | Lactate dehydrogenase panel - Serum or Plasma |
897 | 40703-1 | Lactoferrin [Presence] in Stool by Immunoassay |
898 | 11051-0 | Lambda light chains [Mass/volume] in Serum or Plasma |
899 | 33944-0 | Lambda light chains.free [Mass/volume] in Serum or Plasma |
900 | 6948-4 | lamoTRIgine [Mass/volume] in Serum or Plasma |
901 | 6158-0 | Latex IgE Ab [Units/volume] in Serum |
902 | 5671-3 | Lead [Mass/volume] in Blood |
903 | 10912-4 | Lead [Mass/volume] in Serum or Plasma |
904 | 14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
905 | 38901-5 | Leflunomide [Mass/volume] in Serum or Plasma |
906 | 41499-5 | Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay |
907 | 49914-5 | Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum |
908 | 30046-7 | Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay |
909 | 588-4 | Legionella pneumophila Ag [Presence] in Specimen by Immunofluorescence |
910 | 31870-9 | Legionella pneumophila Ag [Presence] in Urine |
911 | 6447-7 | Legionella pneumophila Ag [Presence] in Urine by Immunoassay |
912 | 6448-5 | Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) |
913 | 593-4 | Legionella sp identified in Specimen by Organism specific culture |
914 | 6239-8 | Lenscale IgE Ab [Units/volume] in Serum |
915 | 21365-2 | Leptin [Mass/volume] in Serum or Plasma |
916 | 7959-0 | Leptospira sp Ab [Titer] in Serum |
917 | 15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes |
918 | 26464-8 | Leukocytes [#/volume] in Blood |
919 | 6690-2 | Leukocytes [#/volume] in Blood by Automated count |
920 | 13349-6 | Leukocytes [#/volume] in Stool by Manual count |
921 | 13655-6 | Leukocytes [Presence] in Stool by Light microscopy |
922 | 30471-7 | levETIRAcetam [Mass/volume] in Serum or Plasma |
923 | 3714-3 | Lidocaine [Mass/volume] in Serum or Plasma |
924 | 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid |
925 | 3040-3 | Lipase [Enzymatic activity/volume] in Serum or Plasma |
926 | 24331-1 | Lipid 1996 panel - Serum or Plasma |
927 | 57698-3 | Lipid panel with direct LDL - Serum or Plasma |
928 | 10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
929 | 43583-4 | Lipoprotein a [Moles/volume] in Serum or Plasma |
930 | 3719-2 | Lithium [Mass/volume] in Serum or Plasma |
931 | 14334-7 | Lithium [Moles/volume] in Serum or Plasma |
932 | 32220-6 | Liver kidney microsomal 1 Ab [Units/volume] in Serum |
933 | 9838-4 | Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence |
934 | 6165-5 | Lobster IgE Ab [Units/volume] in Serum |
935 | 15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
936 | 3284-7 | Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay |
937 | 10501-5 | Lutropin [Units/volume] in Serum or Plasma |
938 | 54227-4 | Lymphoma - acute screen panel - Specimen by Flow cytometry (FC) |
939 | 54228-2 | Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC) |
940 | 54229-0 | Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC) |
941 | 54226-6 | Lymphoma panel - Specimen by Flow cytometry (FC) |
942 | 29956-0 | Lysozyme [Mass/volume] in Body fluid |
943 | 11183-1 | Macadamia IgE Ab [Units/volume] in Serum |
944 | 24447-5 | Magnesium [Mass/time] in 24 hour Urine |
945 | 26746-8 | Magnesium [Mass/volume] in Red Blood Cells |
946 | 19123-9 | Magnesium [Mass/volume] in Serum or Plasma |
947 | 19124-7 | Magnesium [Mass/volume] in Urine |
948 | 2597-3 | Magnesium [Moles/volume] in Red Blood Cells |
949 | 2601-3 | Magnesium [Moles/volume] in Serum or Plasma |
950 | 7477-3 | Mango Pollen IgE Ab [Units/volume] in Serum |
951 | 12232-5 | Measles virus Ag [Presence] in Specimen by Immunofluorescence |
952 | 20479-2 | Measles virus IgG Ab [Presence] in Serum |
953 | 35275-7 | Measles virus IgG Ab [Presence] in Serum by Immunoassay |
954 | 5244-9 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay |
955 | 2605-4 | Meat fibers [Presence] in Stool by Light microscopy |
956 | 3746-5 | Meperidine [Presence] in Urine |
957 | 5685-3 | Mercury [Mass/volume] in Blood |
958 | 2609-6 | Metanephrines [Mass/time] in 24 hour Urine |
959 | 3773-9 | Methadone [Presence] in Urine |
960 | 19550-3 | Methadone [Presence] in Urine by Screen method |
961 | 70149-0 | Methadone [Presence] in Urine by Screen method >300 ng/mL |
962 | 5693-7 | Methanol [Mass/volume] in Serum or Plasma |
963 | 3786-1 | Methaqualone [Presence] in Urine |
964 | 2614-6 | Methemoglobin/Hemoglobin.total in Blood |
965 | 35492-8 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection |
966 | 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
967 | 14836-1 | Methotrexate [Moles/volume] in Serum or Plasma |
968 | 13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma |
969 | 30003-8 | Microalbumin [Mass/volume] in 24 hour Urine |
970 | 14957-5 | Microalbumin [Mass/volume] in Urine |
971 | 58431-8 | Microalbumin panel - 24 hour Urine |
972 | 58448-2 | Microalbumin ug/min [Mass/time] in 24 hour Urine |
973 | 58447-4 | Microalbumin/Creatinine panel in 24H Urine |
974 | 34535-5 | Microalbumin/Creatinine panel in random Urine |
975 | 51714-4 | Microscopic observation [Identifier] in Blood by Giemsa stain |
976 | 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
977 | 19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
978 | 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
979 | 18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
980 | 49050-8 | Microscopic observation [Identifier] in Endocervical brush by Cyto stain |
981 | 11545-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain |
982 | 655-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun modified |
983 | 10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain |
984 | 664-3 | Microscopic observation [Identifier] in Specimen by Gram stain |
985 | 666-8 | Microscopic observation [Identifier] in Specimen by India ink prep |
986 | 667-6 | Microscopic observation [Identifier] in Specimen by KOH preparation |
987 | 20431-3 | Microscopic observation [Identifier] in Specimen by Smear |
988 | 680-9 | Microscopic observation [Identifier] in Specimen by Wet preparation |
989 | 681-7 | Microscopic observation [Identifier] in Specimen by Wright stain |
990 | 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
991 | 6473-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain |
992 | 11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
993 | 32819-5 | Microsporidia identified in Stool by Trichrome stain |
994 | 6174-7 | Milk IgE Ab [Units/volume] in Serum |
995 | 17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence |
996 | 5247-2 | Mitochondria Ab [Titer] in Serum by Immunofluorescence |
997 | 14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum |
998 | 16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method |
999 | 3830-7 | Morphine [Presence] in Urine |
1000 | 6178-8 | Mountain Juniper IgE Ab [Units/volume] in Serum |
1001 | 28005-7 | MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
1002 | 21709-1 | MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
1003 | 38415-6 | MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
1004 | 6182-0 | Mucor racemosus IgE Ab [Units/volume] in Serum |
1005 | 6183-8 | Mugwort IgE Ab [Units/volume] in Serum |
1006 | 38476-8 | Mullerian inhibiting substance [Mass/volume] in Serum or Plasma |
1007 | 22415-4 | Mumps virus IgG Ab [Presence] in Serum |
1008 | 6476-6 | Mumps virus IgG Ab [Presence] in Serum by Immunoassay |
1009 | 7966-5 | Mumps virus IgG Ab [Units/volume] in Serum |
1010 | 25418-5 | Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
1011 | 25419-3 | Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay |
1012 | 533-0 | Mycobacterium sp identified in Blood by Organism specific culture |
1013 | 543-9 | Mycobacterium sp identified in Specimen by Organism specific culture |
1014 | 23905-3 | Mycophenolate [Mass/volume] in Serum or Plasma |
1015 | 42621-3 | Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection |
1016 | 29257-3 | Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
1017 | 5255-5 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
1018 | 58733-7 | Mycoplasma pneumoniae IgG and IgM panel - Serum |
1019 | 5256-3 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
1020 | 23301-5 | Mycoplasma sp DNA [Presence] in Specimen by NAA with probe detection |
1021 | 2638-5 | Myelin basic protein [Mass/volume] in Cerebral spinal fluid |
1022 | 6969-0 | Myeloperoxidase Ab [Units/volume] in Serum |
1023 | 46266-3 | Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay |
1024 | 53833-0 | Myoglobin [Mass/volume] in Blood |
1025 | 2639-3 | Myoglobin [Mass/volume] in Serum or Plasma |
1026 | 2641-9 | Myoglobin [Mass/volume] in Urine |
1027 | 2640-1 | Myoglobin [Presence] in Urine |
1028 | 3834-9 | N-acetylprocainamide [Mass/volume] in Serum or Plasma |
1029 | 42637-9 | Natriuretic peptide B [Mass/volume] in Blood |
1030 | 30934-4 | Natriuretic peptide B [Mass/volume] in Serum or Plasma |
1031 | 33762-6 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma |
1032 | 698-1 | Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture |
1033 | 47387-6 | Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
1034 | 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection |
1035 | 21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
1036 | 50388-8 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
1037 | 32198-4 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe |
1038 | 43305-2 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection |
1039 | 5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe |
1040 | 53927-0 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection |
1041 | 60256-5 | Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
1042 | 6186-1 | Nettle IgE Ab [Units/volume] in Serum |
1043 | 41617-2 | Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) |
1044 | 21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum |
1045 | 48050-9 | Neutrophils [Presence] in Stool by Wright stain |
1046 | 54089-8 | Newborn screening panel American Health Information Community (AHIC) |
1047 | 18244-4 | Niacin [Mass/volume] in Serum or Plasma |
1048 | 3854-7 | Nicotine [Mass/volume] in Urine |
1049 | 33716-2 | Non-gynecological cytology study |
1050 | 35622-0 | Nordiazepam [Mass/volume] in Serum or Plasma by Screen method |
1051 | 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
1052 | 3861-2 | Nordiazepam [Presence] in Urine |
1053 | 3872-9 | Nortriptyline [Mass/volume] in Serum or Plasma |
1054 | 8061-4 | Nuclear Ab [Presence] in Serum |
1055 | 47383-5 | Nuclear Ab [Presence] in Serum by Immunoassay |
1056 | 29953-7 | Nuclear Ab [Titer] in Serum |
1057 | 5048-4 | Nuclear Ab [Titer] in Serum by Immunofluorescence |
1058 | 27200-5 | Nuclear Ab [Units/volume] in Serum |
1059 | 5047-6 | Nuclear Ab [Units/volume] in Serum by Immunoassay |
1060 | 63486-5 | Nut allergen panel - Serum |
1061 | 6190-3 | Oat IgE Ab [Units/volume] in Serum |
1062 | 24364-2 | Obstetric 1996 panel - Serum and Blood |
1063 | 56764-4 | Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing |
1064 | 8220-6 | Opiates [Mass/volume] in Urine |
1065 | 8214-9 | Opiates [Presence] in Meconium |
1066 | 8216-4 | Opiates [Presence] in Meconium by Screen method |
1067 | 3879-4 | Opiates [Presence] in Urine |
1068 | 18390-5 | Opiates [Presence] in Urine by Confirmatory method |
1069 | 19295-5 | Opiates [Presence] in Urine by Screen method |
1070 | 70151-6 | Opiates [Presence] in Urine by Screen method >300 ng/mL |
1071 | 6194-5 | Orange IgE Ab [Units/volume] in Serum |
1072 | 2692-2 | Osmolality of Serum or Plasma |
1073 | 2695-5 | Osmolality of Urine |
1074 | 2697-1 | Osteocalcin [Mass/volume] in Serum or Plasma |
1075 | 673-4 | Ova and parasites identified in Specimen by Light microscopy |
1076 | 10701-1 | Ova and parasites identified in Stool by Concentration |
1077 | 10704-5 | Ova and parasites identified in Stool by Light microscopy |
1078 | 2701-1 | Oxalate [Mass/time] in 24 hour Urine |
1079 | 2700-3 | Oxalate [Mass/volume] in Urine |
1080 | 14862-7 | Oxalate [Moles/time] in 24 hour Urine |
1081 | 16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method |
1082 | 12361-2 | Oxazepam [Presence] in Urine |
1083 | 35331-8 | OXcarbazepine [Mass/volume] in Serum or Plasma |
1084 | 16249-5 | oxyCODONE [Mass/volume] in Urine by Confirmatory method |
1085 | 10998-3 | oxyCODONE [Presence] in Urine |
1086 | 19643-6 | oxyCODONE [Presence] in Urine by Confirmatory method |
1087 | 17395-5 | oxyMORphone [Mass/volume] in Urine by Confirmatory method |
1088 | 18325-1 | oxyMORphone [Presence] in Urine by Confirmatory method |
1089 | 7558-0 | Oyster IgE Ab [Units/volume] in Serum |
1090 | 56687-7 | Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence |
1091 | 13327-2 | Parainfluenza virus Ag [Presence] in Specimen by Immunofluorescence |
1092 | 2729-2 | Parathyrin related protein [Mass/volume] in Serum or Plasma |
1093 | 2731-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma |
1094 | 5271-2 | Parietal cell Ab [Titer] in Serum by Immunofluorescence |
1095 | 8087-9 | Parietal cell Ab [Units/volume] in Serum |
1096 | 55164-8 | Paroxysmal nocturnal panel - Blood |
1097 | 29675-6 | Parvovirus B19 IgG Ab [Presence] in Serum |
1098 | 29660-8 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
1099 | 25630-5 | Parvovirus B19 IgG Ab [Titer] in Serum |
1100 | 7983-0 | Parvovirus B19 IgG Ab [Units/volume] in Serum |
1101 | 5273-8 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay |
1102 | 7981-4 | Parvovirus B19 IgM Ab [Presence] in Serum |
1103 | 40658-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay |
1104 | 25631-3 | Parvovirus B19 IgM Ab [Titer] in Serum |
1105 | 7984-8 | Parvovirus B19 IgM Ab [Units/volume] in Serum |
1106 | 5274-6 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay |
1107 | 14869-2 | Pathologist review of Blood tests |
1108 | 6204-2 | Pea IgE Ab [Units/volume] in Serum |
1109 | 6206-7 | Peanut IgE Ab [Units/volume] in Serum |
1110 | 6208-3 | Pecan or Hickory Nut IgE Ab [Units/volume] in Serum |
1111 | 6209-1 | Pecan or Hickory Tree IgE Ab [Units/volume] in Serum |
1112 | 6851-0 | Penicillin G IgE Ab [Units/volume] in Serum |
1113 | 6212-5 | Penicillium notatum IgE Ab [Units/volume] in Serum |
1114 | 7369-2 | Perennial rye grass IgE Ab [Units/volume] in Serum |
1115 | 2748-2 | pH of Body fluid |
1116 | 2749-0 | pH of Gastric fluid |
1117 | 2755-7 | pH of Stool |
1118 | 2756-5 | pH of Urine |
1119 | 5803-2 | pH of Urine by Test strip |
1120 | 8234-7 | Phencyclidine [Presence] in Meconium by Screen method |
1121 | 3936-2 | Phencyclidine [Presence] in Urine |
1122 | 19659-2 | Phencyclidine [Presence] in Urine by Screen method |
1123 | 14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
1124 | 3948-7 | PHENobarbital [Mass/volume] in Serum or Plasma |
1125 | 29573-3 | Phenylalanine [Moles/volume] in DBS |
1126 | 14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma |
1127 | 29571-7 | Phenylalanine [Presence] in DBS |
1128 | 3968-5 | Phenytoin [Mass/volume] in Serum or Plasma |
1129 | 3969-3 | Phenytoin Free [Mass/volume] in Serum or Plasma |
1130 | 2779-7 | Phosphate [Mass/time] in 24 hour Urine |
1131 | 2777-1 | Phosphate [Mass/volume] in Serum or Plasma |
1132 | 2778-9 | Phosphate [Mass/volume] in Urine |
1133 | 30165-5 | Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid |
1134 | 32031-7 | Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay |
1135 | 9326-0 | Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay |
1136 | 32032-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay |
1137 | 9327-8 | Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay |
1138 | 14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum |
1139 | 32033-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay |
1140 | 9622-2 | Phytonadione [Mass/volume] in Serum or Plasma |
1141 | 6733-0 | Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) |
1142 | 10954-6 | Pine Nut IgE Ab [Units/volume] in Serum |
1143 | 7613-3 | Pistachio IgE Ab [Units/volume] in Serum |
1144 | 637-9 | Plasmodium sp identified in Blood by Thick film |
1145 | 33594-3 | Platelet factor 4 [Presence] in Platelet poor plasma |
1146 | 6002-0 | Platelet factor 4 [Units/volume] in Platelet poor plasma |
1147 | 72257-9 | Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood |
1148 | 26515-7 | Platelets [#/volume] in Blood |
1149 | 777-3 | Platelets [#/volume] in Blood by Automated count |
1150 | 700-5 | Pneumocystis jiroveci Ag [Presence] in Specimen by Immunofluorescence |
1151 | 5716-6 | Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma |
1152 | 6219-0 | Pork IgE Ab [Units/volume] in Serum |
1153 | 6298-4 | Potassium [Moles/volume] in Blood |
1154 | 2823-3 | Potassium [Moles/volume] in Serum or Plasma |
1155 | 2828-2 | Potassium [Moles/volume] in Urine |
1156 | 6220-8 | Potato IgE Ab [Units/volume] in Serum |
1157 | 14338-8 | Prealbumin [Mass/volume] in Serum or Plasma |
1158 | 2837-3 | Pregnenolone [Mass/volume] in Serum or Plasma |
1159 | 7632-3 | Privet IgE Ab [Units/volume] in Serum |
1160 | 3982-6 | Procainamide [Mass/volume] in Serum or Plasma |
1161 | 2839-9 | Progesterone [Mass/volume] in Serum or Plasma |
1162 | 27882-0 | Proinsulin [Moles/volume] in Serum or Plasma |
1163 | 2842-3 | Prolactin [Mass/volume] in Serum or Plasma |
1164 | 20568-2 | Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
1165 | 3545-1 | Propoxyphene [Mass/volume] in Urine |
1166 | 19141-1 | Propoxyphene [Presence] in Urine |
1167 | 19429-0 | Propoxyphene [Presence] in Urine by Screen method |
1168 | 17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine |
1169 | 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma |
1170 | 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
1171 | 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
1172 | 19201-3 | Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
1173 | 20420-6 | Prostatic acid phosphatase [Mass/volume] in Serum |
1174 | 2889-4 | Protein [Mass/time] in 24 hour Urine |
1175 | 21482-5 | Protein [Mass/volume] in 24 hour Urine |
1176 | 2881-1 | Protein [Mass/volume] in Body fluid |
1177 | 2880-3 | Protein [Mass/volume] in Cerebral spinal fluid |
1178 | 2885-2 | Protein [Mass/volume] in Serum or Plasma |
1179 | 2888-6 | Protein [Mass/volume] in Urine |
1180 | 35663-4 | Protein [Mass/volume] in Urine collected for unspecified duration |
1181 | 6007-9 | Protein C [Units/volume] in Platelet poor plasma by Coagulation assay |
1182 | 27818-4 | Protein C actual/normal in Platelet poor plasma by Chromogenic method |
1183 | 27819-2 | Protein C actual/normal in Platelet poor plasma by Coagulation assay |
1184 | 6009-5 | Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay |
1185 | 27820-0 | Protein C Ag actual/normal in Platelet poor plasma by Immunoassay |
1186 | 24351-9 | Protein electrophoresis panel - Serum or Plasma |
1187 | 5892-5 | Protein S [Units/volume] in Platelet poor plasma by Coagulation assay |
1188 | 27822-6 | Protein S actual/normal in Platelet poor plasma by Coagulation assay |
1189 | 27823-4 | Protein S Ag actual/normal in Platelet poor plasma by Immunoassay |
1190 | 27821-8 | Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay |
1191 | 2890-2 | Protein/Creatinine [Mass Ratio] in Urine |
1192 | 6968-2 | Proteinase 3 Ab [Units/volume] in Serum |
1193 | 46267-1 | Proteinase 3 Ab [Units/volume] in Serum by Immunoassay |
1194 | 3289-6 | Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay |
1195 | 5902-2 | Prothrombin time (PT) |
1196 | 2895-1 | Protoporphyrin.zinc [Mass/volume] in Red Blood Cells |
1197 | 29763-0 | Protoporphyrin.zinc [Molar ratio] in Red Blood Cells |
1198 | 34528-0 | PT panel - Platelet poor plasma by Coagulation assay |
1199 | 2900-9 | Pyridoxine [Mass/volume] in Serum or Plasma |
1200 | 14121-8 | Pyruvate [Moles/volume] in Blood |
1201 | 6222-4 | Queen Palm IgE Ab [Units/volume] in Serum |
1202 | 5290-2 | Reagin Ab [Presence] in Cerebral spinal fluid by VDRL |
1203 | 20507-0 | Reagin Ab [Presence] in Serum by RPR |
1204 | 5292-8 | Reagin Ab [Presence] in Serum by VDRL |
1205 | 22463-4 | Reagin Ab [Presence] in Serum from Donor |
1206 | 31147-2 | Reagin Ab [Titer] in Serum by RPR |
1207 | 32147-1 | Reducing substances [Mass/volume] in Urine |
1208 | 11060-1 | Reducing substances [Presence] in Stool |
1209 | 5809-9 | Reducing substances [Presence] in Urine |
1210 | 24362-6 | Renal function 2000 panel - Serum or Plasma |
1211 | 2915-7 | Renin [Enzymatic activity/volume] in Plasma |
1212 | 48841-1 | Respiratory allergen panel, US - Alaska a - Serum |
1213 | 48932-8 | Respiratory allergen panel, US - Alaska b - Serum |
1214 | 48835-3 | Respiratory allergen panel, US - Arid southwest - Serum |
1215 | 48931-0 | Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum |
1216 | 48837-9 | Respiratory allergen panel, US - California central valley - Serum |
1217 | 48840-3 | Respiratory allergen panel, US - Cascade Pacific northwest a - Serum |
1218 | 48929-4 | Respiratory allergen panel, US - Cascade Pacific northwest b - Serum |
1219 | 48919-5 | Respiratory allergen panel, US - Central Florida - Serum |
1220 | 48831-2 | Respiratory allergen panel, US - Central midwest a - Serum |
1221 | 48925-2 | Respiratory allergen panel, US - Central midwest b - Serum |
1222 | 49020-1 | Respiratory allergen panel, US - Coastal California - Serum |
1223 | 48832-0 | Respiratory allergen panel, US - Great plains states a - Serum |
1224 | 48926-0 | Respiratory allergen panel, US - Great plains states b - Serum |
1225 | 48828-8 | Respiratory allergen panel, US - Greater Ohio valley a - Serum |
1226 | 48923-7 | Respiratory allergen panel, US - Greater Ohio valley b - Serum |
1227 | 49021-9 | Respiratory allergen panel, US - Greater Ohio valley c - Serum |
1228 | 48933-6 | Respiratory allergen panel, US - Hawaii - Serum |
1229 | 48839-5 | Respiratory allergen panel, US - Inland northwest a - Serum |
1230 | 48928-6 | Respiratory allergen panel, US - Inland northwest b - Serum |
1231 | 48838-7 | Respiratory allergen panel, US - Intermountain west a - Serum |
1232 | 48930-2 | Respiratory allergen panel, US - Intermountain west b - Serum |
1233 | 49018-5 | Respiratory allergen panel, US - Intermountain west c - Serum |
1234 | 48825-4 | Respiratory allergen panel, US - Mid Atlantic states - Serum |
1235 | 48918-7 | Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum |
1236 | 48824-7 | Respiratory allergen panel, US - North Atlantic states a - Serum |
1237 | 48916-1 | Respiratory allergen panel, US - North Atlantic states b - Serum |
1238 | 49017-7 | Respiratory allergen panel, US - North Atlantic states c - Serum |
1239 | 48830-4 | Respiratory allergen panel, US - Northern midwest states a - Serum |
1240 | 48924-5 | Respiratory allergen panel, US - Northern midwest states b - Serum |
1241 | 49022-7 | Respiratory allergen panel, US - Northern midwest states c - Serum |
1242 | 49019-3 | Respiratory allergen panel, US - Puerto Rico - Serum |
1243 | 48834-6 | Respiratory allergen panel, US - Rocky mountain states a - Serum |
1244 | 48927-8 | Respiratory allergen panel, US - Rocky mountain states b - Serum |
1245 | 48826-2 | Respiratory allergen panel, US - South Atlantic states a - Serum |
1246 | 48917-9 | Respiratory allergen panel, US - South Atlantic states b - Serum |
1247 | 48829-6 | Respiratory allergen panel, US - South central states - Serum |
1248 | 48921-1 | Respiratory allergen panel, US - Southeast coast - Serum |
1249 | 48836-1 | Respiratory allergen panel, US - Southern coastal California - Serum |
1250 | 48920-3 | Respiratory allergen panel, US - Southern Florida - Serum |
1251 | 48833-8 | Respiratory allergen panel, US - Southwestern grassland states - Serum |
1252 | 48827-0 | Respiratory allergen panel, US - Subtropical Florida - Serum |
1253 | 48922-9 | Respiratory allergen panel, US - West south central states - Serum |
1254 | 5876-8 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay |
1255 | 5877-6 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunofluorescence |
1256 | 9398-9 | Reticulin Ab [Titer] in Serum |
1257 | 4679-7 | Reticulocytes/100 erythrocytes in Blood |
1258 | 17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count |
1259 | 2923-1 | Retinol [Mass/volume] in Serum or Plasma |
1260 | 38496-6 | Retinyl palmitate [Mass/volume] in Serum or Plasma |
1261 | 10331-7 | Rh [Type] in Blood |
1262 | 1314-4 | Rh immune globulin screen [interpretation] |
1263 | 17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum |
1264 | 33910-1 | Rheumatoid factor [Presence] in Serum |
1265 | 5297-7 | Rheumatoid factor [Presence] in Serum by Latex agglutination |
1266 | 15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephelometry |
1267 | 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma |
1268 | 6695-1 | Riboflavin [Mass/volume] in Blood |
1269 | 8091-1 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
1270 | 5301-7 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
1271 | 29374-6 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
1272 | 51928-0 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
1273 | 6230-7 | Rice IgE Ab [Units/volume] in Serum |
1274 | 41476-3 | Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay |
1275 | 41475-5 | Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
1276 | 5880-0 | Rotavirus Ag [Presence] in Stool by Immunoassay |
1277 | 6232-3 | Rough Marsh Elder IgE Ab [Units/volume] in Serum |
1278 | 6233-1 | Rough Pigweed IgE Ab [Units/volume] in Serum |
1279 | 22496-4 | Rubella virus Ab [Presence] in Serum |
1280 | 5332-2 | Rubella virus Ab [Presence] in Serum by Latex agglutination |
1281 | 41763-4 | Rubella virus IgG Ab [Titer] in Serum |
1282 | 8014-3 | Rubella virus IgG Ab [Units/volume] in Serum |
1283 | 5334-8 | Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
1284 | 8015-0 | Rubella virus IgM Ab [Units/volume] in Serum |
1285 | 5335-5 | Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay |
1286 | 13177-1 | Russian olive IgE Ab [Units/volume] in Serum |
1287 | 22412-1 | Saccharopolyspora rectivirgula Ab [Presence] in Serum |
1288 | 4024-6 | Salicylates [Mass/volume] in Serum or Plasma |
1289 | 35597-4 | Salicylates [Mass/volume] in Serum or Plasma by Screen method |
1290 | 4023-8 | Salicylates [Presence] in Serum or Plasma |
1291 | 6237-2 | Salmon IgE Ab [Units/volume] in Serum |
1292 | 43371-4 | Salmonella and Shigella sp identified in Stool by Organism specific culture |
1293 | 6234-9 | Saltwort IgE Ab [Units/volume] in Serum |
1294 | 7691-9 | Scallop IgE Ab [Units/volume] in Serum |
1295 | 25757-6 | Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay |
1296 | 5348-8 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay |
1297 | 27416-7 | SCL-70 extractable nuclear Ab [Units/volume] in Serum |
1298 | 48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
1299 | 5724-0 | Selenium [Mass/volume] in Serum or Plasma |
1300 | 54231-6 | Semen analysis fertility panel |
1301 | 13361-1 | Semen analysis panel |
1302 | 50677-4 | Semen analysis post vasectomy panel |
1303 | 2939-7 | Serotonin [Mass/volume] in Blood |
1304 | 27057-9 | Serotonin [Mass/volume] in Serum |
1305 | 6242-2 | Sesame Seed IgE Ab [Units/volume] in Serum |
1306 | 6138-2 | Setomelanomma rostrata IgE Ab [Units/volume] in Serum |
1307 | 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
1308 | 6244-8 | Sheep Sorrel IgE Ab [Units/volume] in Serum |
1309 | 6246-3 | Shrimp IgE Ab [Units/volume] in Serum |
1310 | 15283-5 | Silver Birch IgE Ab [Units/volume] in Serum |
1311 | 29247-4 | Sirolimus [Mass/volume] in Blood |
1312 | 5352-0 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
1313 | 5351-2 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay |
1314 | 17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
1315 | 33569-5 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
1316 | 5354-6 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
1317 | 5353-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay |
1318 | 17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
1319 | 45142-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
1320 | 5357-9 | Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
1321 | 5356-1 | Smith extractable nuclear Ab [Presence] in Serum by Immunoassay |
1322 | 11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum |
1323 | 43182-5 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
1324 | 27048-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
1325 | 21522-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
1326 | 41053-0 | SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
1327 | 14252-1 | Smooth muscle Ab [Presence] in Serum |
1328 | 8095-2 | Smooth muscle Ab [Titer] in Serum |
1329 | 5358-7 | Smooth muscle Ab [Titer] in Serum by Immunofluorescence |
1330 | 2956-1 | Sodium [Moles/time] in 24 hour Urine |
1331 | 21525-1 | Sodium [Moles/volume] in 24 hour Urine |
1332 | 2947-0 | Sodium [Moles/volume] in Blood |
1333 | 2951-2 | Sodium [Moles/volume] in Serum or Plasma |
1334 | 2955-3 | Sodium [Moles/volume] in Urine |
1335 | 35678-2 | Sodium [Moles/volume] in Urine collected for unspecified duration |
1336 | 38420-6 | Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay |
1337 | 2963-7 | Somatotropin [Mass/volume] in Serum or Plasma |
1338 | 6248-9 | Soybean IgE Ab [Units/volume] in Serum |
1339 | 2965-2 | Specific gravity of Urine |
1340 | 5811-5 | Specific gravity of Urine by Test strip |
1341 | 51623-7 | Spermatozoa [#/volume] in Semen --post vasectomy |
1342 | 6252-1 | Stemphylium botryosum IgE Ab [Units/volume] in Serum |
1343 | 6257-0 | Strawberry IgE Ab [Units/volume] in Serum |
1344 | 14207-5 | Streptococcal DNAse B [Titer] in Serum |
1345 | 582-7 | Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture |
1346 | 586-8 | Streptococcus agalactiae [Presence] in Specimen by Organism specific culture |
1347 | 585-0 | Streptococcus agalactiae [Presence] in Throat by Organism specific culture |
1348 | 584-3 | Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture |
1349 | 11266-4 | Streptococcus agalactiae Ag [Presence] in Specimen |
1350 | 6551-6 | Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence |
1351 | 48683-7 | Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection |
1352 | 5034-4 | Streptococcus agalactiae rRNA [Presence] in Specimen by Probe |
1353 | 24027-5 | Streptococcus pneumoniae Ag [Presence] in Urine |
1354 | 11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
1355 | 6559-9 | Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence |
1356 | 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat |
1357 | 78012-2 | Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay |
1358 | 5036-9 | Streptococcus pyogenes rRNA [Presence] in Specimen by Probe |
1359 | 547-0 | Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture |
1360 | 546-2 | Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture |
1361 | 22568-0 | Streptolysin O Ab [Titer] in Serum |
1362 | 5370-2 | Streptolysin O Ab [Units/volume] in Serum or Plasma |
1363 | 34376-4 | Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay |
1364 | 11529-5 | Surgical pathology study |
1365 | 11253-2 | Tacrolimus [Mass/volume] in Blood |
1366 | 32721-3 | Tacrolimus [Mass/volume] in Serum or Plasma |
1367 | 65758-5 | T-cell helper (CD4) subset panel - Blood |
1368 | 65759-3 | T-cell subsets CD4 and CD8 panel - Blood |
1369 | 21751-3 | TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
1370 | 2986-8 | Testosterone [Mass/volume] in Serum or Plasma |
1371 | 49041-7 | Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
1372 | 2991-8 | Testosterone Free [Mass/volume] in Serum or Plasma |
1373 | 49042-5 | Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
1374 | 25987-9 | Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
1375 | 8169-5 | Tetrahydrocannabinol [Presence] in Meconium by Screen method |
1376 | 3426-4 | Tetrahydrocannabinol [Presence] in Urine |
1377 | 19415-9 | Tetrahydrocannabinol [Presence] in Urine by Screen method |
1378 | 4049-3 | Theophylline [Mass/volume] in Serum or Plasma |
1379 | 2998-3 | Thiamine [Mass/volume] in Blood |
1380 | 2999-1 | Thiamine [Mass/volume] in Serum or Plasma |
1381 | 32554-8 | Thiamine [Moles/volume] in Blood |
1382 | 20468-5 | Thiamine [Moles/volume] in Serum or Plasma |
1383 | 21563-2 | Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells |
1384 | 14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
1385 | 3243-3 | Thrombin time |
1386 | 3013-0 | Thyroglobulin [Mass/volume] in Serum or Plasma |
1387 | 15210-8 | Thyroglobulin Ab [Presence] in Serum |
1388 | 5381-9 | Thyroglobulin Ab [Titer] in Serum by Latex agglutination |
1389 | 8098-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma |
1390 | 38505-4 | Thyroglobulin recovery in Serum or Plasma |
1391 | 30166-3 | Thyroid stimulating immunoglobulins actual/normal in Serum |
1392 | 32786-6 | Thyroperoxidase Ab [Titer] in Serum or Plasma |
1393 | 8099-4 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma |
1394 | 29574-1 | Thyrotropin [Presence] in DBS |
1395 | 3016-3 | Thyrotropin [Units/volume] in Serum or Plasma |
1396 | 11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
1397 | 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
1398 | 57416-0 | Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay |
1399 | 31144-9 | Thyroxine (T4) [Mass/volume] in DBS |
1400 | 3026-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma |
1401 | 38506-2 | Thyroxine (T4) [Presence] in DBS |
1402 | 3024-7 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma |
1403 | 6892-4 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis |
1404 | 3021-3 | Thyroxine binding globulin [Mass/volume] in Serum or Plasma |
1405 | 6265-3 | Timothy IgE Ab [Units/volume] in Serum |
1406 | 35280-7 | Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay |
1407 | 31017-7 | Tissue transglutaminase IgA Ab [Units/volume] in Serum |
1408 | 46128-5 | Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay |
1409 | 55727-2 | Tissue transglutaminase IgA and IgG panel - Serum |
1410 | 32998-7 | Tissue transglutaminase IgG Ab [Units/volume] in Serum |
1411 | 56537-4 | Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
1412 | 35670-9 | Tobramycin [Mass/volume] in Serum or Plasma |
1413 | 4057-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak |
1414 | 4059-2 | Tobramycin [Mass/volume] in Serum or Plasma --trough |
1415 | 6266-1 | Tomato IgE Ab [Units/volume] in Serum |
1416 | 17713-9 | Topiramate [Mass/volume] in Serum or Plasma |
1417 | 8039-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum |
1418 | 5388-4 | Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
1419 | 57770-0 | Toxoplasma gondii IgG and IgM panel - Serum |
1420 | 8040-8 | Toxoplasma gondii IgM Ab [Units/volume] in Serum |
1421 | 5390-0 | Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
1422 | 36922-3 | TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
1423 | 19710-3 | traMADol [Presence] in Urine by Screen method |
1424 | 3034-6 | Transferrin [Mass/volume] in Serum or Plasma |
1425 | 30248-9 | Transferrin receptor.soluble [Mass/volume] in Serum or Plasma |
1426 | 22587-0 | Treponema pallidum Ab [Presence] in Serum |
1427 | 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination |
1428 | 24110-9 | Treponema pallidum Ab [Presence] in Serum by Immunoassay |
1429 | 5393-4 | Treponema pallidum Ab [Presence] in Serum by Immunofluorescence |
1430 | 41163-7 | Treponema pallidum DNA [Presence] in Specimen by NAA with probe detection |
1431 | 6561-5 | Treponema pallidum IgG Ab [Presence] in Serum |
1432 | 47238-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay |
1433 | 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
1434 | 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
1435 | 6565-6 | Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation |
1436 | 6568-0 | Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe |
1437 | 46154-1 | Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection |
1438 | 4073-3 | Tricyclic antidepressants [Presence] in Serum or Plasma |
1439 | 11004-9 | Tricyclic antidepressants [Presence] in Urine |
1440 | 19312-8 | Tricyclic antidepressants [Presence] in Urine by Screen method |
1441 | 3043-7 | Triglyceride [Mass/volume] in Blood |
1442 | 2571-8 | Triglyceride [Mass/volume] in Serum or Plasma |
1443 | 3053-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma |
1444 | 3051-0 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma |
1445 | 3052-8 | Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma |
1446 | 3054-4 | Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma |
1447 | 3050-2 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma |
1448 | 42757-5 | Troponin I.cardiac [Mass/volume] in Blood |
1449 | 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
1450 | 49563-0 | Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
1451 | 6598-7 | Troponin T.cardiac [Mass/volume] in Serum or Plasma |
1452 | 21582-2 | Tryptase [Mass/volume] in Serum or Plasma |
1453 | 6270-3 | Tuna IgE Ab [Units/volume] in Serum |
1454 | 35571-9 | Tyrosine [Moles/volume] in DBS |
1455 | 20660-7 | Tyrosine [Moles/volume] in Serum or Plasma |
1456 | 3087-4 | Urate [Mass/time] in 24 hour Urine |
1457 | 3084-1 | Urate [Mass/volume] in Serum or Plasma |
1458 | 3086-6 | Urate [Mass/volume] in Urine |
1459 | 3092-4 | Urea [Mass/volume] in Urine |
1460 | 22738-9 | Urea [Moles/volume] in Specimen |
1461 | 3096-5 | Urea nitrogen [Mass/time] in 24 hour Urine |
1462 | 6299-2 | Urea nitrogen [Mass/volume] in Blood |
1463 | 3093-2 | Urea nitrogen [Mass/volume] in Body fluid |
1464 | 3094-0 | Urea nitrogen [Mass/volume] in Serum or Plasma |
1465 | 11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
1466 | 11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
1467 | 3095-7 | Urea nitrogen [Mass/volume] in Urine |
1468 | 3097-3 | Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma |
1469 | 32637-1 | Urease [Presence] in Tissue |
1470 | 24356-8 | Urinalysis complete panel - Urine |
1471 | 58077-9 | Urinalysis complete W Reflex Culture panel - Urine |
1472 | 57020-0 | Urinalysis dipstick W Reflex Microscopic panel - Urine |
1473 | 24357-6 | Urinalysis macro (dipstick) panel - Urine |
1474 | 3107-0 | Urobilinogen [Mass/volume] in Urine |
1475 | 20405-7 | Urobilinogen [Mass/volume] in Urine by Test strip |
1476 | 19161-9 | Urobilinogen [Units/volume] in Urine by Test strip |
1477 | 4086-5 | Valproate [Mass/volume] in Serum or Plasma |
1478 | 20578-1 | Vancomycin [Mass/volume] in Serum or Plasma |
1479 | 4090-7 | Vancomycin [Mass/volume] in Serum or Plasma --peak |
1480 | 4092-3 | Vancomycin [Mass/volume] in Serum or Plasma --trough |
1481 | 9624-8 | Vanillylmandelate [Mass/volume] in Urine |
1482 | 43099-1 | Vanillylmandelate and Creatinine panel - 24 hour Urine |
1483 | 22600-1 | Varicella zoster virus Ab [Presence] in Serum |
1484 | 49451-8 | Varicella zoster virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
1485 | 19162-7 | Varicella zoster virus IgG Ab [Presence] in Serum |
1486 | 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
1487 | 8047-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum |
1488 | 5403-1 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
1489 | 5404-9 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
1490 | 3125-2 | Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma |
1491 | 3126-0 | Vasopressin [Mass/volume] in Serum or Plasma |
1492 | 6164-8 | Virginia Live Oak IgE Ab [Units/volume] in Serum |
1493 | 6584-7 | Virus identified in Specimen by Culture |
1494 | 3128-6 | Viscosity of Serum |
1495 | 35365-6 | Vitamin D+Metabolites [Mass/volume] in Serum or Plasma |
1496 | 6012-9 | von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
1497 | 27816-8 | von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay |
1498 | 53622-7 | von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method |
1499 | 32217-2 | von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma |
1500 | 6014-5 | von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation |
1501 | 38370-3 | Voriconazole [Mass/volume] in Serum or Plasma |
1502 | 6273-7 | Walnut IgE Ab [Units/volume] in Serum |
1503 | 32361-8 | West Nile virus RNA [Presence] in Serum by NAA with probe detection |
1504 | 6276-0 | Wheat IgE Ab [Units/volume] in Serum |
1505 | 6278-6 | White Ash IgE Ab [Units/volume] in Serum |
1506 | 41874-9 | White Birch IgE Ab [Units/volume] in Serum |
1507 | 6109-3 | White Elm IgE Ab [Units/volume] in Serum |
1508 | 13183-9 | White Elm IgG Ab [Units/volume] in Serum |
1509 | 7407-0 | White Hickory IgE Ab [Units/volume] in Serum |
1510 | 6281-0 | White mulberry IgE Ab [Units/volume] in Serum |
1511 | 6189-5 | White Oak IgE Ab [Units/volume] in Serum |
1512 | 7291-8 | Whole Egg IgE Ab [Units/volume] in Serum |
1513 | 6286-9 | Wormwood IgE Ab [Units/volume] in Serum |
1514 | 45042-9 | XXX microorganism Ag [Identifier] in Specimen by Immunofluorescence |
1515 | 35691-5 | XXX microorganism DNA [Presence] in Specimen by NAA with probe detection |
1516 | 18482-0 | Yeast [Presence] in Specimen by Organism specific culture |
1517 | 701-3 | Yersinia sp identified in Specimen by Organism specific culture |
1518 | 5763-8 | Zinc [Mass/volume] in Serum or Plasma |
1519 | 25557-0 | Zinc [Moles/volume] in Red Blood Cells |
1520 | 29620-2 | Zonisamide [Mass/volume] in Serum or Plasma |